In the first trading day of April, some cannabis-related stocks from our global databases fared worse than the others. In alphabetical order by ticker symbol, the 3 biggest marijuana stock losers in trading on Monday, April 3rd, 2017 are as follows:
Tetra Bio-Pharma Inc.
Despite their earlier announcement of a development and commercialization partnership with IntelGenx to produce a Dronabinol tablet, shares of Tetra Bio-Pharma Inc. (CSE:TBP)(OTC:GRPOF)(FRA:JAM1) closed Monday's trading down more than 2%. We're working on creating a marijuana stock profile for Tetra Bio-Pharma so be sure to subscribe to our free newsletter so you are updated when it becomes available.
OWC Pharmaceutical Research Corp.
In the trading day today, shares of OWC Pharmaceutical Research Corp. (OTC:OWCP) fell more than 9% without any recent news. Find more about OWC Pharmaceutical Research by visiting their stock profile in our marijuana stock database linked above.
Canopy Growth Corp.
Following today's trading, shares of Canopy Growth Corp. (TSX:WEED)(OTC:TWMJF)(FRA:11L1) were down more than 4%. This move comes after this morning's announcement that they have entered into an agreement to acquire late stage ACMPR applicant, rTrees Producers Limited.
Conclusion
If you see a marijuana company here that grabs your attention, find out more by checking out their stock profile in our marijuana stock database via the linked ticker symbols.
Also, keep up with cannabis stock and industry updates from the Daily Marijuana Observer by following us on social media and by subscribing to our email newsletter found below.
Now check out today's biggest marijuana stock gainers.
Disclaimer
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.
